Icon

ADDYI (nda022526)- (100MG)

FLIBANSERIN SPROUT PHARMS
100MG
No No
2028-May-09 2020-Aug-18
None None
None No
ADDYI is indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to:  A co-existing medical or psychiatric condition,  Problems within the relationship, or  The effects of a medication or other drug substance.
0 0 0
Total Other Developers 2
Drugs with Suitability No
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.